Viewing Study NCT02119468


Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2026-02-24 @ 2:07 PM
Study NCT ID: NCT02119468
Status: COMPLETED
Last Update Posted: 2024-03-15
First Post: 2014-04-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Plasma Cell Myeloma View
None Recurrent Plasma Cell Myeloma View
Keywords: